SHIRI ET AL.
11 of 13
solvent‐free conditions. Reaction progress was monitored by
TLC (acetone: n‐hexane, 3:7). After completion of the reac-
tion, the catalyst was separated using an external magnet
and washed with ethyl acetate. Then, the solvent was evapo-
rated and all products were recrystallized from ethanol. The
pure polyhydroquinoline derivatives were obtained in excel-
lent yields (91–98%).
4.9.4 | 2‐(4‐Chlorobenzylidene)malononitrile
(4a):
1H NMR (400 MHz, DMSO‐d6): δH = 7.74 (d, J = 8.8 Hz,
2H), 7.97 (d, J = 8.8 Hz, 2H), 8.73 (s, 1H). 13C–NMR
(100 MHz, DMSO) δC = 82.7, 113.5 (CN), 114.5 (CN),
115.7 (2C), 130.5, 132.6 (2C), 139.5, 160.6.
4.9.5 | Ethyl (E)‐2‐Cyano‐3‐(4‐methylphenyl)‐
2‐propenoate (4p):
4.9 | Spectroscopic data
1H NMR (400 MHz, DMSO‐d6) δH
=
1.26 (t,
All the products reported here are known compounds and the
spectroscopic data was matched literature values. Data for the
some of the compounds are given below.
J = 7.2 Hz, 3H), 2.4 (S, 3H), 3.54 (q, J = 7.2 Hz, 2H)
7.1 (d, J = 8 Hz, 2H), 7.45–7.47 (d, J = 8 Hz, 2H),
8.03 (s, 1H). 13C–NMR (100 MHz, DMSO‐d6) δC = 15.24
(CH3), 55.31 (CH3O), 65.39 (O‐CH2), 102.33 (C‐CN),
113.77 (CN), 121.36, 126.51, 132.22, 139.33, 152.57,
162.26 (C = O).
4.9.1 | 2‐phenyl‐2,3‐dihydroquinazolin‐4(1H)‐
one (2a):
1H NMR (400 MHz, DMSO‐d6): δH = 5.77 (s, 1H), 6.69
(t, J = 8 Hz, 1H, Ar‐H), 6.77 (d, J = 7.6 Hz, 1H, Ar‐H),
7.13 (brs, 1H, N‐H), 7.26 (td, J = 8, 1.6 Hz, 1H, Ar‐H),
7.34–7.43 (m, 3H, Ar‐H), 7.51 (dd, J = 6.8, 1.2 Hz, 2H,
Ar‐H), 7.63 (dd, J = 7.6, 1.2 Hz, 1H, Ar‐H), 8.31 (brs,
1H, N‐H). 13C NMR (100 MHz, DMSO‐d6) δC = 67.1,
114.9, 115.4, 117.6, 127.4, 127.9, 128.8, 129, 133.8,
142.1, 148.4, 164.1.
4.9.6 | Ethyl‐4‐(4‐Fluoro‐phenyl)‐2,7,7‐
trimethyl‐5‐oxo‐1,4,5,6,7,8‐hexahydroquinoline‐
3‐carboxylate (6c)
1H NMR (400 MHz, DMSO‐d6) δH = 0.85 (s, 3H), 1.02
(s, 3H), 1.13 (t, J = 7.2 Hz, 3H), 1.99 (d, J = 16 Hz,
1H), 2.18 (d, J = 16 Hz, 1H), 2.28–2.32 (m, 4H), 2.43
(d, J = 16.8 Hz, 1H), 3.98 (q, J = 7.2 Hz, 2H), 4.87
(s, 1H), 6.99–7.20 (m, 4H, Ar‐H), 9.11 (brs, 1H, N‐H).
13C NMR (100 MHz, DMSO‐d6) δC = 14.6, 18.8, 26.7,
29.6, 32.6, 35.8, 39.8, 50.7, 59.5, 74.32, 103.9, 110.4,
114.7, 129.6, 144.3, 145.7, 149.95, 159.71–162.11
(JCF = 240 HZ), 167.2, 194.7.
4.9.2 | 2‐(4‐Chlorophenyl)‐2,3‐
dihydroquinazolin‐4(1H)‐one (2j):
1H NMR (400 MHz, DMSO‐d6): δH = 5.79 (s, 1H), 6.70 (t,
J = 7.6 Hz, 1H, Ar‐H), 6.76 (d, J = 8 Hz, 1H, Ar‐H), 7.16
(brs, 1H, N‐H), 7.24–7.29 (td, J = 7.6, 1.6 Hz, 1H, Ar‐H),
7.46–7.49 (dt, J = 8.8, 2 Hz, 2H, Ar‐H), 7.51–7.53 (dt,
J = 8.4, 2 Hz, 2H, Ar‐H), 7.62 (dd, J = 7.6, 1.6 Hz, 1H,
Ar‐H), 8.35 (brs, 1H, N‐H). 13C NMR (100 MHz, DMSO‐
d6) δC = 66.3, 114.9, 115.4, 117.8, 127.9, 128.8, 129.2,
133.5, 133.9, 141.1, 148.1, 164.
4.9.7 | Ethyl‐4‐phenyl‐2,7,7‐trimethyl‐5‐oxo‐
1,4,5,6,7,8‐hexahydroquinoline‐3‐carboxylate
(6 g)
1H NMR (400 MHz, DMSO‐d6) δH = 0.86 (s, 3H), 1.02 (s,
3H), 1.14 (t, J = 7.2 Hz, 3H), 1.99 (d, J = 16 Hz, 1H),
2.18 (d, J = 16 Hz, 1H), 2.29–2.33 (m, 4H), 2.44 (d,
J = 17.2 Hz, 1H), 3.99 (q, J = 7.2 Hz, 2H), 4.88 (s, 1H),
7.06–7.21 (m, 5H, Ar‐H), 9.07 (brs, 1H, N‐H). 13C NMR
(100 MHz, DMSO‐d6) δC = 14.6, 18.8, 26.9, 29.6, 32.6,
36.4, 50.7, 59.5, 104.1, 110.5, 126.1, 127.9, 128.2, 145.5,
148.1, 150, 167.3, 194.7.
4.9.3 | 2‐(3‐Nitrophenyl)‐2,3‐
dihydroquinazolin‐4(1H)‐one (2 k):
1H NMR (400 MHz, DMSO‐d6): δH = 5.98 (s, 1H), 6.72 (t,
J = 8 Hz, 1H, Ar‐H), 6.82 (d, J = 8 Hz, 1H, Ar‐H), 7.29
(td, J = 6.8, 1.6 Hz, 1H, Ar‐H), 7.38 (brs, 1H, N‐H), 7.65
(dd, J = 8, 1.6 Hz, 1H, Ar‐H), 7.71 (t, J = 8 Hz, 1H, Ar‐
H), 7.97 (d, J = 7.6 Hz, 1H, Ar‐H), 8.23 (dq, J = 8,
1.6 Hz, 1H, Ar‐H), 8.39 (t, J = 2 Hz, 1H, Ar‐H), 8.57
((brs, 1H, N‐H). 13C NMR (100 MHz, DMSO‐d6) δC = 65.7,
115.1, 115.4, 118, 122.1, 123.8, 127.9, 130.5, 133.8, 134.1,
144.7, 147.8, 148.2, 163.9.
4.9.8 | Ethyl‐4‐(3‐Bromo‐phenyl)‐2,7,7‐
trimethyl‐5‐oxo‐1,4,5,6,7,8‐hexahydroquinoline‐
3‐carboxylate (6 h)
1H NMR (400 MHz, DMSO‐d6) δH = 0.87 (s, 3H), 1.03 (s,
3H), 1.14 (t, J = 7.2 Hz, 3H), 2.01 (d, J = 16 Hz, 1H),
2.19 (d, J = 16 Hz, 1H), 2.31–2.34 (m, 4H), 2.45 (d,